Research Updates in Gout and Hyperuricemia

Article

Learn about findings from recent studies of gout, crystalline arthritis, and hyperuricemia.

Created by the Cleveland Clinic, “Advances in Gout and Other Crystal Diseases” is a CME-accredited webcast approved for 0.25 AMA PRA Category 1 Credits. In this 15-minute video, Brian Mandell, MD, PhD, Professor and Chairman, Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Department of Rheumatic and Immunologic Diseases, Center for Vasculitis Care and Research, reviews key studies relating to crystalline arthritis and hyperuricemia, examines an anti-IL1 approach to treating acute gout attacks, and describes the role of the kidney in controlling serum urate levels and potential approaches to treating hyperuricemia.

Click here to access this third-party webcast resource.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
Veeral Sheth, MD: Assessment of EYP-1901 Supplemental Injection Use in Wet AMD | Image Credit: University Retina
© 2024 MJH Life Sciences

All rights reserved.